| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
56,564,000 |
| Market
Cap: |
2.59(B) |
| Last
Volume: |
4,082,242 |
Avg
Vol: |
4,049,369 |
| 52
Week Range: |
$33.85 - $54.82 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 739 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile LivaNova is a medical device company focused on the development and delivery of therapeutic solutions for the benefit of patients, healthcare personnel and healthcare systems. Co.'s principal business franchises, which are also its reportable segments are: Cardiovascular and Neuromodulation. Co.'s cardiovascular business franchise is engaged in the development, production and sale of cardiopulmonary products, heart valves and advanced circulatory support products. Co.'s neuromodulation business franchise designs, develops and markets neuromodulation-based medical devices for the treatment of epilepsy, depression and obstructive sleep apnea.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
2,750 |
59,373 |
| Total Sell Value |
$0 |
$0 |
$133,608 |
$3,537,302 |
| Total People Sold |
0 |
0 |
1 |
2 |
| Total Sell Transactions |
0 |
0 |
2 |
3 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Barry James Christopher |
Director |
– • – |
2025-06-15 |
4 |
D |
$45.76 |
$18,762 |
D/D |
(410) |
4,362 |
|
- |
|
| Barry James Christopher |
Director |
– • – |
2025-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,416 |
4,772 |
|
- |
|
| Wilver Peter M |
Director |
– • – |
2025-06-15 |
4 |
D |
$45.76 |
$18,762 |
D/D |
(410) |
6,738 |
|
- |
|
| Wilver Peter M |
Director |
– • – |
2025-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,416 |
7,148 |
|
- |
|
| Bianchi Francesco |
Director |
– • – |
2025-06-15 |
4 |
D |
$45.76 |
$18,762 |
D/D |
(410) |
10,528 |
|
- |
|
| Bianchi Francesco |
Director |
– • – |
2025-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,416 |
10,938 |
|
- |
|
| Enxing Seng Stacy |
Director |
– • – |
2025-06-15 |
4 |
D |
$45.76 |
$18,762 |
D/D |
(410) |
11,751 |
|
- |
|
| Enxing Seng Stacy |
Director |
– • – |
2025-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,416 |
12,161 |
|
- |
|
| Story Brooke |
Director |
– • – |
2025-06-15 |
4 |
D |
$45.76 |
$18,762 |
D/D |
(410) |
6,482 |
|
- |
|
| Story Brooke |
Director |
– • – |
2025-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,416 |
6,892 |
|
- |
|
| Kozy William A |
Director |
– • – |
2025-06-15 |
4 |
D |
$45.76 |
$26,587 |
D/D |
(581) |
32,567 |
|
- |
|
| Kozy William A |
Director |
– • – |
2025-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,840 |
33,148 |
|
- |
|
| Okane Sharon |
Director |
– • – |
2025-06-15 |
4 |
D |
$45.76 |
$73,491 |
D/D |
(1,606) |
11,304 |
|
- |
|
| Okane Sharon |
Director |
– • – |
2025-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,416 |
12,910 |
|
- |
|
| Tezel Ahmet |
Chief Innovation Officer |
• – – |
2025-06-15 |
4 |
D |
$45.76 |
$47,224 |
D/D |
(1,032) |
1,935 |
|
- |
|
| Tezel Ahmet |
Chief Innovation Officer |
• – – |
2025-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,967 |
2,967 |
|
- |
|
| Schermerhorn Todd C |
Director |
– • – |
2025-06-15 |
4 |
D |
$45.76 |
$18,762 |
D/D |
(410) |
9,063 |
|
- |
|
| Schermerhorn Todd C |
Director |
– • – |
2025-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,416 |
9,473 |
|
- |
|
| Kozy William A |
Director |
– • – |
2025-03-30 |
4 |
D |
$39.13 |
$7,356 |
D/D |
(188) |
28,308 |
|
- |
|
| Kozy William A |
Director |
– • – |
2025-03-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,034 |
28,496 |
|
- |
|
| Poletti Franco |
President, Cardiopulmonary |
• – – |
2025-03-30 |
4 |
D |
$39.13 |
$21,208 |
D/D |
(542) |
7,933 |
|
- |
|
| Poletti Franco |
President, Cardiopulmonary |
• – – |
2025-03-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,257 |
8,475 |
|
- |
|
| Shvartsburg Alex |
Chief Financial Officer |
• – – |
2025-03-30 |
4 |
D |
$39.13 |
$137,581 |
D/D |
(3,516) |
26,680 |
|
- |
|
| Shvartsburg Alex |
Chief Financial Officer |
• – – |
2025-03-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,083 |
30,196 |
|
- |
|
| Bolton Stephanie |
President, Global Epilepsy |
• – – |
2025-03-30 |
4 |
D |
$39.13 |
$110,934 |
D/D |
(2,835) |
12,751 |
|
- |
|
585 Records found
|
|
Page 1 of 24 |
|
|
0.05 (0.11%) 
